NASDAQ: SGP
Spyglass Pharma Inc Earnings Dates, Reports, Calls

Spyglass Pharma earnings were N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest SGP earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$13.8M, up 10.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SGP reported annual earnings of -$39.9M, with 36.7% growth. The next SGP earnings date is Aug 13, 2026.

SGP earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

SGP Return on Equity

Insufficient data to display

SGP Return on Assets

Insufficient data to display

Be the first to know when SGP announces earnings.

SGP Return on Capital Employed

Current Company
0%
Current Industry
-9.6%

SGP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SGPN/AN/AN/AN/A
RLMD-$58.88M-$58.88MN/A-$1.11
RIGL$131.28M$364.23M+863.33%$20.23
CADL-$49.96M-$54.42MN/A-$0.99
NVCT-$27.16M-$29.59MN/A-$1.31

SGP earnings dates

Next earnings date
Aug 13, 2026

Spyglass Pharma Earnings Reports & History FAQ

What were Spyglass Pharma's earnings last quarter?

On SGP's earnings call on Invalid Date, Spyglass Pharma (NASDAQ: SGP) reported Q1 2026 earnings per share (EPS) of -$0.69, up 82.58% year over year. Total SGP earnings for the quarter were -$13.82 million. In the same quarter last year, Spyglass Pharma's earnings per share (EPS) was -$3.96.

If you're new to stock investing, here's how to buy Spyglass Pharma stock.

When does Spyglass Pharma report earnings?

The next SGP earnings date is Invalid Date. Add SGP to your watchlist to be reminded of Spyglass Pharma's next earnings date.

Is Spyglass Pharma profitable or losing money?

As of the last Spyglass Pharma earnings report, Spyglass Pharma is currently losing money. Spyglass Pharma's net profit (also called net income) for the twelve months ending Mar 31, 2026 was N/A, a N/A decrease year over year.

What was SGP's earnings growth in the past year?

As of Spyglass Pharma's earnings date in Invalid Date, Spyglass Pharma's earnings has grown year over year. SGP earnings in the past year totalled N/A.

What are Spyglass Pharma's earnings expectations?

The current EPS estimate for Spyglass Pharma's earnings report in Invalid Date is -$0.48.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.